CIK: 0001782539 · Show all filings
Period: Q1 2025 (← Previous) (Next →)
Filing Date: May 14, 2025
Total Value ($000): $122,618 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| HRMY | HARMONY BIOSCIENCES HLDGS IN | 368,665 | $12,236 | 10.0% | $30.00 | +19.5% | COM | 413197104 |
| OCS | OCULIS HOLDING AG | 514,702 | $9,795 | 8.0% | $11.25 | +82.2% | ORDINARY SHARES | H5870P102 |
| ILMN | ILLUMINA INC | 119,196 | $9,457 | 7.7% | $459.88 | -76.5% | COM | 452327109 |
| — | VERONA PHARMA PLC | 147,990 | $9,396 | 7.7% | $48.16 | — | SPONSORED ADS | 925050106 |
| ZLAB | ZAI LAB LTD | 253,675 | $9,168 | 7.5% | $23.55 | — | ADR | 98887Q104 |
| MIRM | MIRUM PHARMACEUTICALS INC | 146,765 | $6,612 | 5.4% | $33.95 | +38.8% | COM | 604749101 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 121,400 | $5,871 | 4.8% | $41.90 | 0.0% | COM | 74366E102 |
| SLNO | SOLENO THERAPEUTICS INC | 79,650 | $5,691 | 4.6% | $48.65 | +0.1% | COM | 834203309 |
| XENE | XENON PHARMACEUTICALS INC | 158,605 | $5,321 | 4.3% | $24.83 | +52.9% | COM | 98420N105 |
| — | MERUS N V | 120,038 | $5,052 | 4.1% | $27.41 | — | COM | N5749R100 |
| ONC | BEIGENE LTD | 15,722 | $4,279 | 3.5% | $213.29 | — | SPONSORED ADR | 07725L102 |
| REPL | REPLIMUNE GROUP INC | 414,246 | $4,039 | 3.3% | $14.30 | -13.4% | COM | 76029N106 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 11,872 | $3,932 | 3.2% | $247.63 | +32.7% | COM | 558868105 |
| INCY | INCYTE CORP | 59,022 | $3,574 | 2.9% | $63.22 | +10.3% | COM | 45337C102 |
| RXRX | RECURSION PHARMACEUTICALS IN | 664,610 | $3,516 | 2.9% | $6.72 | +8.4% | CL A | 75629V104 |
| — | TOURMALINE BIO INC | 227,090 | $3,454 | 2.8% | $15.52 | — | COM | 89157D105 |
| RYTM | RHYTHM PHARMACEUTICALS INC | 49,120 | $2,602 | 2.1% | $27.85 | +99.2% | COM | 76243J105 |
| EXEL | EXELIXIS INC | 64,200 | $2,370 | 1.9% | $23.32 | +52.8% | COM | 30161Q104 |
| GERN | GERON CORP | 1,373,550 | $2,184 | 1.8% | $2.56 | -4.9% | COM | 374163103 |
| ASND | ASCENDIS PHARMA A/S | 13,600 | $2,120 | 1.7% | $151.17 | — | SPONSORED ADR | 04351P101 |
| LAB | STANDARD BIOTOOLS INC | 1,883,179 | $2,034 | 1.7% | $2.41 | -41.8% | COM | 34385P108 |
| KALV | KALVISTA PHARMACEUTICALS INC | 154,522 | $1,783 | 1.5% | $13.67 | -25.4% | COM | 483497103 |
| ACAD | ACADIA PHARMACEUTICALS INC | 102,984 | $1,711 | 1.4% | $23.42 | -22.4% | COM | 004225108 |
| ARGX | ARGENX SE | 2,800 | $1,657 | 1.4% | $584.22 | — | SPONSORED ADR | 04016X101 |
| KYMR | KYMERA THERAPEUTICS INC | 30,875 | $845 | 0.7% | $41.86 | -12.9% | COM | 501575104 |
| RVMD | REVOLUTION MEDICINES INC | 19,253 | $681 | 0.6% | $42.57 | -4.6% | COM | 76155X100 |
| RANI | RANI THERAPEUTICS HLDGS INC | 493,584 | $622 | 0.5% | $17.30 | -91.4% | COM CL A | 753018100 |
| BCYC | BICYCLE THERAPEUTICS PLC | 68,943 | $585 | 0.5% | $17.35 | — | SPONSORED ADS | 088786108 |
| CLYM | CLIMB BIO INC | 463,654 | $566 | 0.5% | $7.07 | -77.1% | COM | 28658R106 |
| — | BOLT BIOTHERAPEUTICS INC | 1,166,952 | $467 | 0.4% | $15.46 | — | COM | 097702104 |
| TRDA | ENTRADA THERAPEUTICS INC | 49,082 | $444 | 0.4% | $9.39 | — | COM | 29384C108 |
| DBVT | DBV TECHNOLOGIES S A | 37,095 | $253 | 0.2% | $3.09 | — | SPONSORED ADS | 23306J309 |
| — | BOLT PROJS HLDGS INC | 811,952 | $250 | 0.2% | $0.82 | — | COM | 09769B107 |
| AFMDQ | AFFIMED N V | 37,247 | $27 | 0.0% | $5.69 | -82.1% | ORDINARY SHS NEW | N01045207 |
| ALXO | ALX ONCOLOGY HLDGS INC | 41,950 | $26 | 0.0% | $60.98 | -98.0% | COM | 00166B105 |